Mondelez International, Inc. (NASDAQ:MDLZ) caters to the Consumer Goods space. It has a net profit margin of 6.50% and weekly performance is -0.80%. On the last day of trading company shares ended up at $46.16. Mondelez International, Inc. (NASDAQ:MDLZ) distance from 50-day simple moving average (SMA50) is 5.49%.
Mondelez International, Inc. (NASDAQ:MDLZ) reported its third quarter 2015 results, reflecting continued strong Adjusted Operating Income [1] margin expansion and solid Organic Net Revenue [1] growth. Adjusted EPS [1] was flat versus the prior year on a constant-currency basis due to dilution related to the company’s recently created coffee joint venture. On a reported basis, net revenues were $6.8 billion, down 17.8 percent, including a negative 13.6 percentage point impact from currency and a negative 9.3 percentage points from the coffee business transactions. Operating income was $7.8 billion, up 815 percent, including a $7.1 billion pre-tax gain from the coffee transaction. Diluted EPS was $4.46, up $3.93.
Sony Corp (ADR) (NYSE:SNE) shares increased 1.07% in last trading session and ended the day at $28.40. SNE Gross Margin is 35.80% and its has a return on assets of -0.80%. Sony Corp (ADR) (NYSE:SNE) quarterly performance is 2.31%.
Sony Corp (ADR) (NYSE:SNE) returned to profit last quarter in a sign its marathon restructuring effort is beginning to produce results.The Tokyo-based electronics and entertainment conglomerate on Thursday reported a 33.6 billion yen ($278 million) profit for the fiscal second quarter, compared with a loss of 136 billion a year earlier. Sales dropped 0.5 percent to 1.89 trillion yen ($15.6 billion). Sony’s Xperia mobile phone business was still struggling in a market dominated by Apple Inc.’s iPhone and Samsung’s Galaxy phones. But Sony did well in devices, including image sensors and other semiconductors, in addition to games, home audio equipment and cameras.
Microsoft Corporation (NASDAQ:MSFT) caters to the Technology space. It has a net profit margin of 13.50% and weekly performance is -0.44%. On the last day of trading company shares ended up at $52.64. Microsoft Corporation (NASDAQ:MSFT) distance from 50-day simple moving average (SMA50) is -8.89%.
Microsoft Corporation (NASDAQ:MSFT) has improved its productivity suite, Microsoft Office, with the introduction of new features. What makes Office a premium choice among users is not only the features it has to offer, but a few other reasons such as presence of limited alternatives as well as the suite’s availability on other platforms. However, Microsoft has a strong competitor in the web-based productivity software, Google Docs. The search-giant’s online office suite enjoys a fair share in the market, which Microsoft plans to take away. This being the reason the company has announced the addition of some new features in Office Online.
On 30 October, Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares decreased -0.98% and was closed at $61.41. ACHC EPS growth in last 5 year was 56.50%. Acadia Healthcare Company, Inc. (NASDAQ:ACHC) year to date (YTD) performance is 0.33%.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) announced that it will release its third quarter 2015 earnings on Tuesday, November 3, 2015, after the market closes. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Wednesday, November 4, 2015.
Imperva Inc. (NYSE:IMPV) caters to the Technology space. It has a net profit margin of -33.00% and weekly performance is 17.62%. On the last day of trading company shares ended up at $70.62. Imperva Inc. (NYSE:IMPV) distance from 50-day simple moving average (SMA50) is 10.50%.
Imperva (NYSE: IMPV) reported Q3 EPS of $0.19, $0.24 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $63.3 million versus the consensus estimate of $56.5 million.Imperva sees Q4 2015 EPS of $0.10-$0.16, versus the consensus of ($0.06). Imperva sees Q4 2015 revenue of $66-68 million, versus the consensus of $62.3 million. Imperva sees FY2015 EPS of $0.00-$0.07, versus the consensus of $0.44. Imperva sees FY2015 revenue of $227.6-229.6 million, versus the consensus of $217 million.
Leave a Reply